tm logo
REDOXOPHORE
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 02 Oct 2004

Last Applicant/ Owned by

5301 Patrick Henry Drive

Santa Clara

CA

95054

Serial Number

76354629 filed on 03rd Jan 2002

Registration Number

N/A

Correspondent Address

Lynn M. Humphreys

John L. Slafsky

650 Page Mill Road

Palo Alto CA 94304-1050

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

REDOXOPHORE

Pharmaceutical preparations for the treatment of inflammatory and ischemic disorders, namely systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, autoimmune diabetes, skin inflammation including atopic dermatitis, contact dermatitis, allergic dermatisis, xerosis, eczema, rosacea, seborrhea, psoriasis, thermal and radiation burns, acne, oily skin, wrinkles Read More

Classification Information


Class [001]
Chemical Products


chemical additives for use in the manufacture of pharmaceuticals, skin care preparations, and dietary and nutritional supplements

Class [003]
Cosmetics and Cleaning Products


Non-medicated skin care preparations, namely creams, lotions, cleansers, moisturizers, astringents, emollients, exfoliators, sunscreens, mousses, toners, masks, powders, foundations, cosmetics, gels, pastes, roll-ons, patches, pads, tissues, wipes, antiperspirants, deodorants, nail polish, hair conditioners, shampoos, scalp treatments

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of inflammatory and ischemic disorders, namely systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, autoimmune diabetes, skin inflammation including atopic dermatitis, contact dermatitis, allergic dermatisis, xerosis, eczema, rosacea, seborrhea, psoriasis, thermal and radiation burns, acne, oily skin, wrinkles, excessive cellulite, excessive pore size, intrinsic skin aging, photo aging, photo damage, harmful UV damage, keratinization abnormalities, alopecia, dyspigmentation inflammation due to wounds, scarring or stretch marks, loss of elasticity, skin atrophy, pigmentation control, psoriasis, inhibition of hair growth, inhibition of hair loss, stimulation of hair growth, gingivitis, central nervous system ischemia resulting from cardiac arrest, hypoxemia, transient ischemic attack, stroke or severe hypotension; cerebral ischemia including stroke, ischemic heart disease myocardial ischemia), spinal cord ischemia and paraplegia, retinal ischemia including age-related macular degeneration (ARMD), hepatic ischemia, renal ischemia, dermal ischemia, penile ischemia, pulmonary ischemia, gastric ischemia intestinal ischemia, splenic ischemia, pancreatic ischemia, skeletal muscle ischemia, ischemia associated with diabetic ulcers, gangrenous conditions, post-trauma syndrome, benign prostatic hyperplasia of hypertrophy (BPH), post prostate cancer surgery, cardiac arrest resuscitation, peripheral nerve damage or neuropathise, and dietary and nutritional supplements

Mark Details


Serial Number

No 76354629

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 346392400800

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Mar 2005ABANDONMENT - NO USE STATEMENT FILED
09th Mar 2005ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
10th Aug 2004CASE FILE IN TICRS
12th Jul 2004PAPER RECEIVED
12th Jul 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
11th Jun 2004EXTENSION 2 GRANTED
11th Mar 2004EXTENSION 2 FILED
11th Mar 2004TEAS EXTENSION RECEIVED
19th Dec 2003EXTENSION 1 GRANTED
19th Sep 2003EXTENSION 1 FILED